Combining USP8 genotype with tumor size identifies Cushing disease patients at high recurrence risk, even with low postoperative cortisol.
The investigational drug tonlamarsen—which is designed to lower blood pressure by reducing the production of angiotensinogen, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results